• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

SCORPIO

Sars-COV-2 vaccine ResPonse In Obesity

  • Home
  • Researchers
  • Visit Info
    • Trial locations
    • COVID-19
  • Papers
  • Funding
  • News
  • Contact us
Illustration of COVID particles

New COVID vaccine studies announced

You are here: Home / COVID-19 / New COVID vaccine studies announced
November 15, 2021 by Jacqui Brocker

The SCORPIO (Sars-COV-2 vaccine ResPonse In Obesity) study is one of five new COVID-19 vaccine projects funded by the UKRI. You can read more about the SCORPIO Study on this website, and more about the four other projects on the UKRI website here: https://www.ukri.org/news/five-new-covid-19-vaccine-research-projects-announced/

Category: COVID-19, SCORPIO

Contact Us

Email: genetics.ofobesity@nhs.net

University of Cambridge Metabolic Research Laboratories
Level 4, Institute of Metabolic Science
Box 289, Addenbrooke’s Hospital
Cambridge, CB2 0QQ

Copyright © 2023 · SCORPIO · All Rights Reserved · Hosted by CSCS

Back to top